Have ALLHAT, ANBP2, ASCOT-BPLA, and So Forth Improved Our Knowledge About Better Hypertension Care?

This publication has 34 references indexed in Scilit:

• Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes
  The American Journal of Cardiology, 2005
• Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia
  Journal of Human Hypertension, 2004
• Hydrochlorothiazide Versus Chlorthalidone
  Hypertension, 2004
• Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
  Hypertension, 2003
• Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
  JAMA, 2002
• High remaining risk in poorly treated hypertension: the ‘rule of halves’ still exists
  Journal Of Hypertension, 2002
• Effects of intensified antihypertensive treatment in diabetic nephropathy
  Journal Of Hypertension, 1999
• AUSTRALIAN COMPARATIVE OUTCOME TRIAL OF ANGIOTENSIN‐CONVERTING ENZYME INHIBITOR‐ AND DIURETIC‐BASED TREATMENT OF HYPERTENSION IN THE ELDERLY (ANBP2): OBJECTIVES PROTOCOL
  Clinical and Experimental Pharmacology and Physiology, 1997
• Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party.
  BMJ, 1992
• Treatment of hypertension in the elderly: I. Blood pressure and clinical changes. Results of a Department of Veterans Affairs Cooperative Study.
  Hypertension, 1990